Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 21,970 | 23,097 | 24,512 | 28,153 | 25,363 |
| Cost of Goods | 9,205 | 9,879 | 9,740 | 11,828 | 10,636 |
| Gross Profit | 12,765 | 13,218 | 14,772 | 16,325 | 14,727 |
| Operating Expenses | 14,844 | 16,166 | 17,791 | 16,871 | 16,296 |
| Operating Income | -1,874 | -2,069 | -2,279 | 282 | -933 |
| Interest Expense | 856 | 749 | 751 | 794 | 882 |
| Other Income | -1,761 | -462 | -1,454 | -591 | 1,253 |
| Pre-tax Income | -4,491 | -3,280 | -4,484 | -1,103 | -562 |
| Income Tax | 311 | -353 | 210 | 715 | 677 |
| Net Income Continuous | -4,802 | -2,927 | -4,694 | -1,818 | -1,239 |
| Net Income | $-4,802 | $-2,927 | $-4,694 | $-1,818 | $-1,239 |
| EPS Basic Total Ops | -1.10 | -0.70 | -1.10 | -0.40 | -0.30 |
| EPS Basic Continuous Ops | -1.10 | -0.67 | -1.08 | -0.43 | -0.29 |
| EPS Diluted Total Ops | -1.10 | -0.70 | -1.10 | -0.40 | -0.30 |
| EPS Diluted Continuous Ops | -1.10 | -0.67 | -1.08 | -0.43 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.30 | 0.00 | N/A | N/A |
| EBITDA(a) | $30 | $-198 | $-428 | $2,129 | $916 |